HealthcareServices

Global Cell Therapy Processing Market Report 2026–2030: Data-Driven Growth Insights

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy processing market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Cell Therapy Processing Market be in 2030 compared with 2026?

The cell therapy processing market has witnessed swift expansion in recent years. It is anticipated to grow from $5.18 billion in 2025 to $5.92 billion in 2026, at a compound annual growth rate (CAGR) of 14.3%. The growth observed in the historic period can be ascribed to increasing clinical trials for cell therapies, expansion of biopharmaceutical manufacturing capacity, availability of specialized processing facilities, growing expertise in gmp compliance, and rising investment in advanced therapeutics.

The cell therapy processing market is projected for significant expansion over the coming years, reaching $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast timeframe stems from several factors, including the increasing commercialization of gene and cell therapies, a rising demand for contract manufacturing services, the expansion of decentralized manufacturing models, the growing adoption of digital quality management systems, and a rise in regulatory approvals for cell-based therapies. Key developments expected during this period involve a greater embrace of GMP-compliant processing platforms, an escalating need for scalable cell therapy manufacturing, the wider integration of workflow automation software, an expansion of contract processing services, and a heightened emphasis on sterility and quality assurance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

What Drivers Are Guiding Growth Patterns In The Cell Therapy Processing Market?

An increasing volume of cell therapy research is anticipated to boost the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic products from live cells to manage or treat a range of conditions such as cancers, autoimmune diseases, and genetic ailments. The rising need for scalable and consistent manufacturing platforms, capable of handling high cell densities without impacting product quality, is fueling the demand for cell-based therapies. For cell therapy research, cell therapy processing is advantageous because it facilitates the standardized preparation, quality control, and scalable production of high-quality cells, thus guaranteeing dependable and repeatable results for both experimental and clinical studies. An example of this trend is that in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit body, reported the launch of six first-in-class cell and gene treatments in 2023. This figure represents a 50% increase compared to the three such treatments released in 2022. Consequently, the increasing volume of cell therapy research activities is a primary factor driving the growth of the cell therapy processing market.

How Is The Cell Therapy Processing Market Divided Into Segments?

The cell therapy processing market covered in this report is segmented –

1) By Offering Type: Products, Services, Software

2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

Subsegments:

1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

Which Market Trends Are Opening Growth Opportunities In The Cell Therapy Processing Market?

Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, including integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system is a unified device that combines cell incubation and centrifugal separation within a single enclosed unit, facilitating continuous, automated cell processing without the necessity for intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT), introduced LimONE, an automated, closed-system platform for cell therapy manufacturing. This innovative system integrates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing stages, such as incubation, centrifugation, and reagent handling, into a singular compact unit, thereby permitting consistent, scalable production of therapies like CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing, bypassing the need for intricate technology transfers.

Which Key Players Are Driving Competition In The Cell Therapy Processing Market?

Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

Which Region Is Projected To Lead The Cell Therapy Processing Market During The Forecast Period?

North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Therapy Processing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

Exterior Insulation And Finish System Market Report 2026

https://www.thebusinessresearchcompany.com/report/exterior-insulation-and-finish-system-global-market-report

Metal Structural Insulation Panels Market Report 2026

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Vacuum Insulation Panel Market Report 2026

https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795